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Impaired trophoblast invasion is associated with pregnancy disorders such as early pregnancy loss
andpreeclampsia. There is evidence to suggest that the consumptionof caffeineduringpregnancy
may increase the risk of pregnancy loss; however, little is known about the direct effect of caffeine
on normal trophoblast biology. Our objectives were to examine the effect of caffeine on tropho-
blast migration and motility after stimulation with epidermal growth factor (EGF) and to inves-
tigate the intracellular signaling pathways involved in this process. Primary first-trimester extravil-
lous trophoblasts (EVT) and the EVT-derived cell line SGHPL-4 were used to study the effect of
caffeine on EGF-stimulated cellular motility using time-lapse microscopy. SGHPL-4 cells were fur-
ther used to study the effect of caffeine and cAMP on EGF-stimulated invasion of fibrin gels. The
influence of caffeine and cAMP on EGF-stimulated intracellular signaling pathways leading to the
activationofAktwere investigatedbyWesternblot analysis. Caffeine inhibits bothEGF-stimulated
primaryEVTandSGHPL-4 cellmotility. EGF stimulationactivatesphosphatidylinositol 3-kinase, and
Akt and caffeine inhibit this activation. Although cAMP inhibits bothmotility and invasion, it does
not inhibit the activation of Akt, indicating that the effects of caffeine seen in this study are
independent of cAMP. Further investigation indicated a role for mammalian target of rapamycin
complex 2 (mTORC2) as a target for the inhibitory effect of caffeine. In conclusion,wedemonstrate
that caffeine inhibits EGF-stimulated trophoblast invasion and motility in vitro and so could ad-
versely influence trophoblast biology in vivo. (Endocrinology 153: 4502–4510, 2012)
Trophoblasts are specialized cells of the placenta thatplay a central role in establishing andmaintaining a suc-
cessful pregnancy. Extravillous trophoblasts (EVT) invade
through the decidua, migrating toward the uterine spiral ar-
terieswhere they interactwith the vesselwall, resulting in the
loss of both endothelial and vascular smooth muscle cells.
The resulting transformation ensures the enhanced delivery
of blood to the developing fetus at a much reduced pressure
(1, 2). Failure of EVT to adequately invade the decidua re-
sults in poor vessel remodeling and a reduction in placental
perfusion, characteristic of common pregnancy complica-
tions such as preeclampsia, intrauterine growth restriction
(IUGR), and even early pregnancy loss (3).
Caffeine is a methylxanthine found naturally in
plants used to make coffee, tea, cocoa/chocolate, and
cola drinks. It is also artificially added to many energy
drinks as well as a range of over-the-counter medica-
tions and, as such, is the most commonly consumed
psychostimulant in the world. The effects of caffeine on
pregnancy outcome are controversial (4–8); however,
several large epidemiological studies have established a
correlation between increased caffeine intake and risk
of miscarriage (4) and IUGR (5). In response to these
latter studies, the United Kingdom Food Standards
Agency changed the recommendation given to pregnant
women advising that they restrict their caffeine intake
during pregnancy (9). The effect of caffeine on the nor-
mal trophoblast functions essential for successful pla-
centation, such as cellular invasion and motility, re-
mains to be comprehensively studied.
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Caffeine is lipid soluble and passes freely across bio-
logical membranes. It has been detected in the preimplan-
tation blastocyst (10) and has been shown to cross the
placenta (11). Caffeine can elicit a number of cellular re-
sponses; it is an inhibitor of cAMP phosphodiesterase
(12), resulting in the elevation of intracellular cAMP, and
it can stimulate calcium release from intracellular stores,
regulate cellular proliferation, and can induce cell cycle
arrest and apoptosis (13). Caffeine can also inhibit tumor
cell invasion (14).
Epidermal growth factor (EGF) is a pluripotent growth
factor that can regulate a number of fundamental cellular
processes including growth, differentiation, invasion, and
apoptosis in numerous cell types. It is secreted by human
endometrium, decidua, and placenta, and both EGF and
its receptors have been isolated in cytotrophoblasts (15).
We and others have shown that EGF plays an important
role in the regulation of trophoblast invasion (16) and
motility and migration (17).
In the light of the controversy over the effects of caffeine
onpregnancy outcome, the aimof our studywas to examine
whether caffeine had any detrimental effect on trophoblast
biology, a crucial determinant of pregnancy success.
Materials and Methods
Unless otherwise stated, all reagents were obtained from Sigma
(Dorset, UK) or VWR (Nottingham, UK).
Cells and reagents
Isolation of EVT
EVT were isolated from first-trimester placentas using the
method of Chui et al. (18). Briefly, villi were dissected from the
placental membrane, washed in Hanks’ balanced salt solution
(37 C, pH 7.5; Biosera, East Sussex, UK) and the wet weight of
the villi recorded. Trypsin digestion buffer (5 ml/g tissue) was
added (0.1% vol/vol) [trypsin (Difco, Scientific Laboratory Sup-
plies,Yorkshire,UK), 4.2mMMgSO4,1MHEPES (pH7.4)]with
5 U/ml deoxyribonuclease, and villi were incubated at 37 C for
15 min. Excess buffer was then removed and replaced by 8 ml
warm Hanks’ balanced salt solution at 37 C. Tissue was gently
agitated, and the supernatant was examined for the presence of
grape-like clusters of EVT. When EVT were present, the super-
natant was collected through a 100-m filter into DMEM/F12
containing 30%(vol/vol) fetal bovine serum (FBS). Thiswashing
process was repeated between 10 and 20 times until the numbers
of EVT clusters in the placental washes began to decrease. The
collected EVT were then centrifuged at 200  g for 5 min, re-
suspended in 2 ml serum-free EVTmedium, and passed through
a 40-m filter. The filtrate was layered onto a Percoll gradient
(20–55%)and centrifuged at 1200 g for 30minwithnobrake.
Two distinct layers of trophoblasts could be identified between
30and45%andwere collected, diluted to50ml inEVTmedium,
and centrifuged at 500 g for 7 min. Cells were resuspended in
DMEM/F12 containing 10% (vol/vol) FBS, 50 U/ml penicillin,
50 g/ml streptomycin, 2.5 g/ml amphotericin B, and 2 mM
L-glutamine and plated onto a 60-mm tissue culture plate for 10
min to remove adherent stromal cells. EVTwere thenplatedonto
a thin layer of Matrigel at a density of 2.5  105 cells per well.
EVT isolated by thismethod had an average purity of 881.9%
(SEM) (n 6) as determined by human leukocyte antigen-G and
cytokeratin-7 double immunocytochemical staining.
ThehumanEVT-derived cell line SGHPL-4wasused (19,20).
These cells are well characterized and sharemany characteristics
with isolated primary cells, including the expression of cytoker-
atin-7 and human leukocyte antigen-G (19, 21). Cells were cul-
tured in Ham’s F10 supplemented with 10% (vol/vol) FBS, pen-
icillin (100 U/ml), streptomycin (100 g/ml), and 2 mM
L-glutamine at 37 C in 5% CO2. Recombinant human EGF was
purchased from Peprotech (London, UK). Modulators of intra-
cellular cAMP and inhibitors were obtained from the following
companies; 8-bromo-cAMP (Biolog, Bremen, Germany), rapa-
mycin, and KU-0063794 (Calibiochem, Nottingham, UK).
Motility assays
Time-lapse digital imagemicroscopy using anOlympus IX70
inverted microscope equipped with a Hamamatsu C4742-95
digital camera was performed to examine cell motility as previ-
ously described (19). The microscope and stage were enclosed
within a heated (37 C) humidified chamber in an atmosphere of
5% CO2 (Solent Scientific, Fareham, UK). Primary EVT were
incubated overnight in DMEM/F12 containing 10% (vol/vol)
FBS, transferred to serum-free medium for 6 h, and then incu-
bated with or without EGF (10 ng/ml) in serum-free culture me-
dium and motility assessed over 24 h. SGHPL-4 cells were in-
cubated in medium containing 0.5% (vol/vol) FBS for 24 h, at
which time they were transferred to the microscope in fresh me-
dium containing vehicle (PBS) or 10 ng/ml EGF. Where appro-
priate, cells were pretreated with the indicated inhibitors for 30
min at 37 C or the vehicle [dimethylsulfoxide (DMSO)] and
subsequently transferred to the microscope chamber in the pres-
enceorabsenceofEGF. Inaccordancewithprevious studies (20),
10 ng/ml was found to be the optimal EGF concentration to
stimulate motility (data not shown) and was therefore used in
this study. Images were captured every 15 min over a period of
24 h (primary EVT) and 6 h (SGHPL-4). Cells were randomly
chosen at the beginning of the experimental sequence and their
movement track manually using Image Pro-Plus software (Me-
dia Cybernetics, Bethesda,MD). Up to 60 cells were tracked per
treatment, and the experiments were repeated on at least three
separate occasions. Visualizing the cells by this way allows both
proliferation and viability to be monitored throughout the ex-
perimental period (19, 20, 22).
Invasion assay
Invasion assays were carried out as a modification of the
method detailed previously (19). In brief, SGHPL-4 cells were
grown to confluence in Ham’s F-10 medium supplemented with
10%(vol/vol) FBS.Approximately 106 cellswere incubatedwith
120l of gelatin-coatedmicro-carrier beads prepared according
to the manufacturer’s recommendations in a flat-bottom con-
tainer and incubated at 37 C for 30 min to allow the cells to
adhere to the beads before being washed gently with PBS. Fibrin
gels were prepared by dissolving bovine fibrinogen (95% of
clottable protein) in calcium- and magnesium-free PBS at 2.5
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mg/ml with 200 U/ml aprotinin (Trasylol, Bayer, Germany) in a
35-mm plate. Individual bead-cell complexes were added to the
fibrinogen and clotting induced by adding thrombin (0.625
U/ml). After the gel had set, 1.5 ml Ham’s F-10 containing 0.5%
(vol/vol) FBSwas layered over the top. Themediumwas allowed
to equilibrate with the gel for 2 h in a 37 C incubator with 5%
CO2 in air and then removed and replaced by fresh medium
containing 0.5% (vol/vol) FBS.
After 16 h, the cells were stimulatedwith 10 ng/ml EGF in the
presence or absence of cAMP at the doses indicated. After 48 h,
imagesof20bead-cell complexesperplatewere taken.Thebeads
were visualized using anOlympus 1 70 invertedmicroscope at
10 magnification, and images were captured using a
Hamamatsu C4742-95 digital camera. Twenty beads were se-
lected at random and the number and length of process deter-
mined using Image Pro-Plus software (Media Cybernetics) (19).
Western blot analysis
SGHPL-4 cells were serum starved for 24 h in Hams F10 con-
taining 0.5% FBS (vol/vol) at 37 C. Primary EVT were culture
overnight in DMEM/F12 containing 10% (vol/vol) FBS, and the
cells were then serum starved for 6 h before experimentation. Cells
were then treated in the absence of serum with 10 ng/ml EGF or
vehicle control (PBS) for 0, 5, 15, 30, or 60 min as stated. Where
indicated, cells were pretreated with DMSO or the appropriate in-
hibitor for 30 min at 37 C before the addition of EGF. Cells were
harvested in 1RIPA buffer containing a protease inhibitor cock-
tail of aprotinin (60g/ml), phenylmethylsulfonyl fluoride (1mM),
and sodium orthovanadate (1 mM). Lysates were sheared three
times by passage through a 27-gauge needle, and cell debris was
removed by centrifugation at 18,000 g at 4 C for 15 min. Total
protein concentrationswere determined using Bradford protein as-
say reagent, and an equal amount of total protein in each well was
resolvedon8–10%(wt/vol)SDS-PAGEgelsbeforetransfer topoly-
vinylidene difluoride membranes (GE Healthcare, Little Chalfont,
UK). Nonspecific reactivity was blocked with 5% (wt/vol) nonfat
driedmilk in Tris-buffered saline containing 0.1% (vol/vol) Tween
20 for 1 h at room temperature. Blots were incubated overnight
with the following antibodies obtained from Cell Signaling Tech-
nology (Danvers,MA)andusedat 1:1000dilutionasper supplier’s
instructions: rabbit anti-mammalian target of rapamycin (mTOR)
(CS-2972), rabbit anti-phospho-mTOR-Ser2481 (CS-2974), rabbit
anti-phospho-rictor-Thr1135 (CS-3806), rabbit anti-phospho-Akt-
Ser473 (CS-9271 orCS-4060), and rabbit anti-phospho-Akt-Ser308
(CS-9275). The blots were then washed in Tris-buffered saline/
0.1%Tween20and incubatedwithgoatantirabbit IgGconjugated
to horseradish peroxidase (1:10000; A5420, Sigma, UK) for 1 h at
room temperature, and antigen-antibody complexeswere detected
using an enhanced chemiluminescence system (Amersham Biosci-
ences, Little Chalfont, UK). Blots were subsequently stripped in
buffer containing 62.5 mM Tris (pH 6.7), 2% (wt/vol) sodium do-
decyl sulfate, and 100 mM -mercaptoethanol and probed with a
rabbit polyclonal antibody tohuman-actinormousemonoclonal
antibody tohumantubulin (1:10000,Ab7291;AbcamCambridge,
UK). Where indicated, Western blots were scanned and the in-
tegrated intensity of each band determined using ImageJ
(http://rsb.info.nih.gov/ij/). Results are expressed as a ratio to
loading control within the same sample.
Statistical analysis
Dataarepresentedas themean SEM.Thedatawereanalyzed
using a repeated-measures ANOVA followed by a Bonferroni
multiple-comparison post hoc test (GraphPad Prism, SanDiego,
CA). Statistical significance was assumed at P  0.05.
Results
Caffeine and 8Br-cAMP inhibited EGF-stimulated
SGHPL-4 cell invasion
EGFstimulated SGHPL-4 invasionof fibrin gels (Fig. 1;
P  0.05; n  3). Caffeine reduced basal trophoblast in-
vasion, but this did not reach statistical significance. In-
hibitionofEGF-stimulated invasionwasobserved at 2mM
FIG. 1. The effect of caffeine and 8Br-cAMP on SGHPL-4 cell invasion.
SGHPL-4 cells were grown on gelatin-coated Cytodex beads
embedded in fibrin gels and cultured for 16 h in medium with 0.5%
(vol/vol) FBS. Before stimulation with EGF (10 ng/ml), the cells were
incubated with either caffeine (A) or 8Br-cAMP (B) for 30 min. After
48 h, images of 20 beads per treatment were taken at random. Both
the number and length of invasive processes were determined. The
results are expressed as means  SEM. *, P  0.05; ***, P  0.001.
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caffeine (Fig. 1A;P0.05; n3). Because oneof themost
studied effects of caffeine is its inhibitory effect on cyclic
nucleotide phosphodiesterases, which results in increased
intracellular cAMP, we examined the effect of the mem-
brane-permeable phosphodiesterase-resistant analog of
cAMP, 8Br-cAMP. This compound significantly inhibited
EGF-stimulated trophoblast invasion of fibrin gels at 0.5,
1, and 2 mM (Fig. 1B; P  0.001; n  3).
Caffeine and 8Br-cAMP inhibited EGF-stimulated
EVT and SGHPL-4 cell motility
Cellular motility is an important component of inva-
sion. To assess the effects of caffeine on primary EVT
motility, cells were followed over 24 h using time-lapse
microscopy. EGF at 10 ng/ml significantly stimulated pri-
maryEVTcellmotility (Fig. 2A;P0.01; n5).Thiswas
significantly inhibited by pretreatment of cells with 2 mM
caffeine for 30 min before the addition of EGF (Fig. 2A;
P  0.05; n  5). As previously reported (20), 10 ng/ml
EGF significantly stimulated SGHPL-4 cell motility (Fig.
2B; P  0.001; n  6), and this was inhibited in a dose-
dependentmanner by caffeine. This reached statistical sig-
nificance at 1mM (P0.05; n6). Therewas also a small
but significant inhibition of basal trophoblast cell motility
at the highest concentration of caffeine used (2 mM; P 
0.05; n 6). 8Br-cAMP significantly inhibited both basal
and EGF-stimulated motility at both concentrations used
(Fig. 2C). To determine whether caffeine exerts its inhib-
itory effect via the elevation of cAMPand the activation of
protein kinase A, we repeated the motility experiments
after preincubation of SGHPL-4 cells with the protein ki-
nase A inhibitor Rp-cAMP, but we were unable to over-
come the inhibitory effect of caffeineonSGHPL-4motility
(Fig. 2D). Caffeine had no effect on either the viability or
the proliferation of trophoblast during the course of the
experiments presented (data not shown).
Caffeine but not 8Br-cAMP inhibited EGF-
stimulated phosphorylation of Akt
To establish a mechanism for the inhibition of EGF-
stimulated motility seen with both caffeine and 8Br-cAMP,
weexaminedsignalingpathwaysknowntobeactivatedafter
stimulationwith EGF (20).We have pre-
viously shown that activation of Akt is
fundamental to the stimulation of tro-
phoblastmotility by EGF, and inhibiting
phosphorylation at Ser473 inhibits motil-
ity (20). Stimulation of SGHPL-4 cells
with EGF for 5 min led to phosphoryla-
tionofAkt at Ser473 andThr308.Caffeine
inhibited Akt phosphorylation at both
sites in a dose-dependentmanner (Fig. 3,
A and B). Densitometric analysis of the
phosphorylation of Akt at Ser473 indi-
cated significant inhibition was reached
with caffeine concentrations greater than
1 mM (P  0.05; n  5) and 2 mM, re-
spectively (P0.01; n3),whereas caf-
feineat2mMsignificantly inhibitedphos-
phorylation at Thr308 (P 0.05; n 5).
8Br-cAMP had no effect on the phos-
phorylation at Ser473, suggesting adiffer-
ence in the mechanisms employed by the
twocompounds (Fig.3C;n3)andsup-
portingthedataobtainedwithRp-cAMP
(Fig. 2D). In subsequent experiments,
only caffeine was used.
mTOR, Akt phosphorylation, and
trophoblast motility
mTOR is associated with two com-
plexes, mTOR complex (mTORC) 1
and 2, which act both downstream and
FIG. 2. Effect of caffeine and 8Br-cAMP on EGF-stimulated primary first-trimester EVT and
SGHPL-4 cell motility. Primary EVT (A) and SGHPL-4 (B–D) were cultured as stated. Before
stimulation with EGF (10 ng/ml), cells were incubated for 30 min with caffeine, 8Br-cAMP, or
Rp-cAMP. Images were taken every 15 min over 24 (primary EVT) and 6 (SGHPL-4) hours.
Cells were selected at random and motility tracked using Image Pro-Plus software. The data
presented are the mean distance moved in pixels  SEM from at least n  5 independent
experiments. *, P  0.05; **, P  0.01; ***, P  0.001.
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upstream of Akt, respectively. Inhibition of mTORC2
phosphorylationby endostatin has recently been shown to
inhibit IGF-II-stimulated trophoblast invasion (23).Toas-
sess the role of mTOR in the action of caffeine, we first
examined the role of mTOR in EGF-stimulated tropho-
blast motility using two inhibitors: rapamycin, which tar-
gets mTORC1, and KU-0063794, which inhibits both
mTORC1 and mTORC2. KU-0063794, but not rapamy-
cin, significantly inhibited trophoblast cellmotility (Fig. 4,
A and B). Phosphorylation of Akt-Ser473 was inhibited by
KU-0063794, reaching significance at 1M(P0.01; n
5) but was not significantly affected by rapamycin (Fig.
4C; n 6). Similarly, EGF-stimulated phosphorylation of
Akt-Ser473 in primary EVT was significantly inhibited by
KU-0063794 at 1 M (P  0.05; n  4) but was not sig-
nificantly inhibitedby rapamycin (Fig. 4D). Stimulationof
trophoblasts with EGF led to a rapid increase in the phos-
phorylation of mTOR at Ser2481, which persisted for at
least 30 min (Fig. 5A). To further probe the involvement
of mTORC2 in EGF-stimulated trophoblast motility, we
examined the phosphorylation of rapamycin-insensitive
companionofmTOR(RICTOR), akey regulatoryprotein
in the mTORC2 that is absent frommTORC1. EGF stim-
ulation of trophoblasts resulted in a rapid increase in the
phosphorylation ofRICTORat Thr1135. Preincubation of
trophoblasts with caffeine significantly inhibited phos-
phorylation of RICTOR-Thr1135 at both 1 and 2mM (Fig.
5B; P  0.001; n  3).
Effect of inhibiting phosphatidylinositol 3 (PI3)-
kinase on mTORC2 activation
To determine whether activation of PI3-kinase could
lead to mTORC2 activation, we examined the effect of
EGF on RICTOR phosphorylation in the presence and
absence of the PI3-kinase inhibitor Ly294002. As deter-
mined previously, EGF stimulated the phosphorylation of
RICTORatThr1135within 5min, and phosphorylation of
Akt-Ser473 was also observed. Incubation of SGHPL-4
cells with 50MLy294002 for 30min before the addition
ofEGF significantly inhibitedboth the phosphorylationof
RICTOR and Akt (Fig. 5C; P  0.01; n  5).
Effect of caffeine on the activation of PI3-kinase
We have previously shown that activation of the p85
subunit of PI3-kinase by themembrane-permeable peptide
740y-p stimulates the motility of SGHPL-4 cells (22). To
determinewhether caffeine inhibits this pathwaybeforeor
after the activation of PI3-kinase, we used 740y-p, which
directly activates the p85 subunit. At 25 and 50 g/ml,
740y-p produced a 1.37-fold (P 0.05, n 6) and 1.49-
fold (P  0.01, n  6) increase in trophoblast motility,
respectively, which was significantly inhibited by caffeine
(Fig. 6).
Discussion
Poor trophoblast function is associated with a number of
pregnancy disorders including preeclampsia, IUGR, and
early pregnancy loss. Several studies have sought to es-
tablish a link between the incidence of these pregnancy
disorders and external factors such as smoking, alcohol,
and caffeine consumption. Caffeine is the most common
xenobiotic consumed during pregnancy and has been the
subject of a number of conflicting epidemiological studies
(5, 6, 8).
In mouse studies, caffeine reduced trophoblast out-
growth (24); however, to date, there are no reports of the
effect it has on human trophoblast biology. In the present
study, both basal and EGF-stimulated trophoblast inva-
sionwas inhibited by caffeine. Caffeinemodulates a num-
ber of intracellular signaling pathways in a dose-depen-
dent manner. At concentrations greater than 0.2 mM,
FIG. 3. Caffeine but not 8Br-cAMP inhibited EGF-stimulated AKT
phosphorylation at Ser473. SGHPL-4 cells were grown in 9-cm dishes
until they reached approximately 80% confluence. Medium was
removed and replaced with 0.5% serum for 16 h. Cells were
incubated in serum-free medium with or without caffeine (A and B) or
8Br-cAMP (C) at the stated concentrations. After 30 min, EGF (10 ng/
ml) was added where appropriate for 5 min. Cell lysates were
collected, and equal amounts of total protein were subjected to
Western blot analysis for the phosphorylation of Akt. The results
presented are representative of at least three independent
experiments.
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caffeine acts as a phosphodiesterase inhibitor, leading to
elevated intracellular cAMP (25). The membrane-perme-
able analogof cAMP,8Br-cAMP,mimicked the inhibitory
effect of caffeine on EGF-stimulated trophoblast invasion
of fibrin gels.Although themechanism responsible for this
is not known, evidence from other cell systems suggests
that both caffeine and cAMP can inhibit the expression
and or activation of matrix metalloproteinase-2 and -9
(26, 27). Because both enzymes are expressed by tropho-
blasts and are active in regulating trophoblast invasion,
their role warrants additional study (28, 29).
Cellular motility is a key component of invasion. We
have shown for the first time that caffeine can inhibit EGF-
stimulated motility of both primary EVT cells and the
EVT-derived cell line SGHPL-4. The binding of EGF to its
receptor induces receptor homo- and heterodimerization
that is essential for the phosphorylation of multiple ty-
rosine (Tyr) residues and the activation of Tyr kinases.
These Tyr residues provide docking sites for specific Src
homology 2-containing proteins (30–33). Stimulation of
trophoblasts with EGF results in the parallel activation of
intracellular pathways involving both PI3-kinase/Akt and
p42/44 MAPK (17). In this study, we investigated how
caffeine might influence pathways leading to the activa-
tion of Akt.
From previous studies, it is known that activation of
Akt after phosphorylation at Ser473 is key to the regulation
of EGF-stimulated motility in these cells (17, 20). We
therefore investigated whether caffeine might act bymod-
ulating the activity of this protein. The current model of
Akt activation proposes that, after EGF receptor occu-
pancy, PI3-kinase is activated and phosphatidylinositol
3,4,5-trisphosphate is generated, which, in turn, mediates
the recruitment of Akt to the plasmamembrane.Maximal
activation of Akt is dependent on the phosphorylation of
two residues, Thr308, which is dependent on the activity of
the enzymePI3-kinase-dependent kinase 1, and Ser
473.We
have found previously that phosphorylation of Akt on
Ser473 is important in regulating EGF-stimulated tropho-
blast motility (20). In this study, we demonstrate that caf-
feine reduces the phosphorylation of Akt at both Thr308
and Ser473. Although we also found a similar inhibitory
effect on motility after stimulation in the presence of 8Br-
cAMP, therewas no change in the phosphorylation of Akt
Ser473, indicating that in trophoblasts the target of inhi-
bition of these two compounds was different. The differ-
FIG. 4. The regulation of trophoblast motility and phosphorylation of AKTSer473 by mTOR. A and B, Time-lapse digital microscopy was performed
on cells that were pretreated for 30 min with the indicated doses of either vehicle (DMSO) or rapamycin (A) or KU-0063794 (B). Cells were then
stimulated with EGF (10 ng/ml), and motility was monitored over a 6-h period. The data presented are the mean distance moved in pixels  SEM
from at least n  5 independent experiments. ***, P  0.001. C and D, SGHPL-4 cells (C) or primary EVT (D) were incubated in serum-free
medium with KU-0063794 or rapamycin for 30 min and then stimulated with EGF for 5 min. Cell lysates were collected, and equal amounts of
total protein were subjected to Western blot analysis and probed for phospho-AktSer473. The results presented are representative of at least three
independent experiments.
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ence in the effect of caffeine and cAMP on Akt phosphor-
ylation seen in this study has also been shown in other cell
types including human endometrial stromal cells (34). In
contrast, however, both caffeine and raised intracellular
cAMP lead to an inhibition in the phosphorylation of Akt
in both thyrocytes and HEK293 cells (35, 36).
Activation of Akt in response to EGF results from the
activationofmTORC2(37), a complexcontainingmTOR
andRICTOR (38). After stimulation of trophoblasts with
EGF, we were able to demonstrate a rapid and sustained
increase in the phosphorylation of mTOR at Ser2481. Al-
though phosphorylation of mTOR at Ser2481 in response
to stimulation has been associated with activation of both
mTORC1 and mTORC2, we were able to exclude the
involvement of complex 1 as EGF stimulatedmotility, and
phosphorylation of Aktser473 was unaffected by the
mTORC1-specific inhibitor rapamycin. Phosphorylation
of mTOR at Ser2481 in response to EGF was sensitive to
inhibition with caffeine. The role of RICTOR in the reg-
ulation of mTORC2 is unclear, because phosphorylation
of Thr1135 has been implicated in both the inhibition and
activation ofmTORC2 (39, 40). Fromour study, wewere
able to demonstrate that EGF stimulated the phosphory-
lation RICTOR Thr1135 in a caffeine-sensitive manner,
suggesting that the target of caffeine is either one of the
other, as yet unidentified, components of mTORC2 or
a component of the pathway that lies upstream of
mTORC2 (41).
Ly294002 regulates the PI3-kinase/Akt pathwayby tar-
geting the binding of ATP to the p110 catalytic subunit of
PI3-kinase (42). To date, evidence would indicate that
EGF receptor activation leads to activation of PI3-kinase-
dependent kinase 1 and phosphorylation of Akt onThr308
in a PI3-kinase-dependent fashion, whereas activation of
mTORC2 results in the phosphorylation of Akt Ser473.
However, we have previously shown that in trophoblasts,
inhibition of PI3-kinase with Ly294002 inhibits motility
and also phosphorylation ofAkt at Ser473 (20). Consistent
with this finding, we demonstrate here that inhibition of
PI3-kinase with Ly294002 significantly inhibited the
phosphorylation of both Akt Ser473 and RICTOR
Thr1135. Furthermore, we were able to demonstrate stim-
ulation of trophoblast motility after activation of the p85
regulatory subunit of PI3-kinase with the cell-permeable
peptide 740y-p could be inhibited by caffeine, suggesting
FIG. 5. Effect of caffeine and Ly294002 on the phosphorylation of
Akt and mTORC2. A, SGHPL-4 cells were grown in media with 0.5%
(vol/vol) serum for 16 h before incubation with EGF (10 ng/ml) for
between 0 and 30 min. Cell lysates were collected, and equal amounts
of total protein were subjected to Western blot analyses for phospho-
AktSer473, phospho-mTORser2481, and mTOR. B and C, Cells were
incubated in serum-free media with either caffeine (B) or Ly294002 (C)
for 30 min before the addition of EGF for 5 min. Cell lysates were
collected, and equal amounts of total protein were subjected to
Western blot analysis and probed for phospho-Akt-Ser473, phospho-
mTORSer2481, or phospho-RICTORThr1135. The results presented are
representative of three independent experiments.
FIG. 6. The effect of caffeine on PI3-kinase-mediated trophoblast
motility. Time-lapse microscopy was performed on cells that were
pretreated for 30 min with caffeine. Cells were then stimulated with
740y-p, the membrane-permeable activator of the p85 subunit of PI3-
kinase, and motility was monitored over a 6-h period. The data
presented are the mean distance moved in pixels  SEM from at least
n  5 independent experiments. *, P  0.05; **, P  0.01; ***, P 
0.001.
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the site of action of caffeine was either at the site of or
downstream from PI3-kinase. This supports a previous
study of purified recombinant PI3-kinase, indicating a di-
rect inhibitory effect of caffeine on the p110 subunit (41).
In conclusion, we have investigated whether caffeine
had any detrimental effect on trophoblast biology, a cru-
cial determinant of pregnancy success. Using first-trimes-
ter EVT and the EVT-derived cell line SGHPL-4, we ex-
amined the effect of caffeine on trophoblast cell motility
and invasion. The most significant findings of this study
were that caffeine significantly inhibited basal and EGF-
stimulated trophoblast invasion and motility in a dose-
dependent manner. Furthermore, this mechanism was
largely independent of the generation of cAMP but was
mediated via inactivation of PI3-kinase andmTORC2, re-
sulting in a failure to activateAkt, a key intermediate in the
intracellular pathway leading to trophoblast invasion and
motility. This suggests theremay be a cellular basis for the
concerns over the consumption of caffeine during early
pregnancy.
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